Artelo Biosciences, Inc. (ARTL)
NASDAQ: ARTL · Real-Time Price · USD
1.300
-0.060 (-4.41%)
At close: Jun 15, 2026, 4:00 PM EDT
1.294
-0.006 (-0.46%)
After-hours: Jun 15, 2026, 7:38 PM EDT
Artelo Biosciences Employees
Artelo Biosciences had 7 employees as of December 31, 2025. The number of employees increased by 1 or 16.67% compared to the previous year.
Employees
7
Change
1
Growth
16.67%
Revenue / Employee
n/a
Profits / Employee
-$1,923,571
Market Cap
4.53M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 7 | 1 | 16.67% |
| Jun 30, 2025 | 5 | 0 | - |
| Mar 31, 2025 | 5 | 0 | - |
| Dec 31, 2024 | 6 | 0 | - |
| Sep 30, 2024 | 5 | 0 | - |
| Jun 30, 2024 | 5 | 0 | - |
| Mar 31, 2024 | 5 | 0 | - |
| Dec 31, 2023 | 6 | -1 | -14.29% |
| Sep 30, 2023 | 5 | 1 | 25.00% |
| Jun 30, 2023 | 5 | 1 | 25.00% |
| Mar 31, 2023 | 5 | 1 | 25.00% |
| Dec 31, 2022 | 7 | 3 | 75.00% |
| Sep 30, 2022 | 4 | - | - |
| Jun 30, 2022 | 4 | - | - |
| Mar 31, 2022 | 4 | - | - |
| Aug 31, 2020 | 3 | 2 | 200.00% |
| May 31, 2020 | 3 | 2 | 200.00% |
| Feb 29, 2020 | 3 | 2 | 200.00% |
| Nov 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| CollPlant Biotechnologies | 39 |
| FibroBiologics | 15 |
| Soligenix | 14 |
| TransCode Therapeutics | 12 |
| Dermata Therapeutics | 9 |
| Alzamend Neuro | 6 |
| Adial Pharmaceuticals | 5 |
| SciSparc | 3 |
ARTL News
- 5 days ago - Artelo Biosciences Presents ART26.12 Human Metabolite Data Demonstrating Favorable Drug Metabolism Characteristics Associated with Clinical Development Success - GlobeNewsWire
- 10 days ago - Artelo Biosciences Proxy statement: Proxy filing - Filings
- 10 days ago - Artelo Biosciences Proxy statement: Proxy filing - Filings
- 10 days ago - Artelo Biosciences Slides: Corporate presentation - Filings
- 20 days ago - Artelo Biosciences Proxy statement: Proxy filing - Filings
- 26 days ago - Artelo Biosciences Slides: Corporate presentation - Filings
- 4 weeks ago - Artelo Biosciences Provides Business Update Outlining Upcoming Milestones and Reports 2026 First Quarter Financial Results - GlobeNewsWire
- 4 weeks ago - Artelo Biosciences Registration statement: Registration filing - Filings